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Available online 21 February 2019This study aimed to develop and characterize the calcium alginate films loadedwith diclofenac sodium and other
hydrophilic polymerswith different degrees of cross-linking obtained by external gelation process. To the formed
films different physicochemical evaluation were performed which showed an initial character of the films. The
films produced by this external gelation process were found thicker (0.031–0.038 mm) and stronger
(51.9–52.9 MPa) but less elastic (2.3%) than those non-cross-linked films (0.029 mm; 39.7 MPa; 4.4%). The
lower water vapor permeability (WVP) values of the films were obtained where maximum level of crosslinking
occurs. Composite films can be cross-linked in presence of external crosslinking agent to improve the quality of
the produced matrices for various uses. The characterization of the film was performed using Differential Scan-
ning Calorimetry (DSC) and Fourier-Transform Infrared Spectroscopy (FT-IR) analysis. The Scanning ElectronMi-
croscopy (SEM) study showed the morphology of treated composite films. The kinetic release studies showed a
sustained release of the drug from the formulated films as it can be prolonged in composite film. The prepared
biodegradable Ca-Alginate bio-composite film may be of clinical importance for its therapeutic benefit.
© 2019 Elsevier B.V. All rights reserved.Keywords:
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Sodium alginate is extensively used in food and pharmaceutical pro-
ductions such as dispersing, thickening, disintegrating agents [1–3], and
as amatrix for the entrapment of drugs, proteins, and cells [4–8]. Now a
day's alginate has been used in the biomedical field for controlled drug
release, cell encapsulation, scaffolds, tissue engineering and for the
preparation of moulds in the dental field [9–12]. It is a water-soluble
salt of alginic acid, a naturally occurring non-toxic polysaccharide
found in all species of brown algae [13]. Alginate has been shown to
have low immunogenicity, biocompatibility, degradability, easily avail-
able and low-cost makes alginate suitable for the preparation of natural
polymeric films as an alternative to synthetic polymeric films [8,14]. As
of a structural information, it contains two uronic acids, β-(1–4)-linked
D-mannuronic acid (M) and α-(1–4) linked L-guluronic acid (G), and is
composed of homopolymeric blocks M–M or G–G, and blocks with analternating sequence of M–G blocks [13]. Moreover, sodium alginate
has a distinguishing property of cross-linking in the presence of multi-
valent cations, such as calcium ions in aqueous media [13] through
the gelation process [8].
Alginate films have defective moisture barriers due to their hydro-
philic nature, but the inclusion of calcium can decrease the water
vapor permeability of these films, creating them more hydrophobic in
nature. Calcium ions can crosslinkwith alginate by unitingG; as a result,
dissimilar fractions of G produce films showing alteredwater vapor per-
meability properties [15,16]. Small drug molecule to biopolymer (pro-
teins) can be released from the alginate gels in an organized fashion,
and the drug release dependent on the nature of the cross-linking
agent and the procedures used for cross-linking [11].
Over the last few years' many researchers have shown the aug-
mented importance of the use of alginates as a polymer for micro-
spheres preparation and use of calcium chloride as a cross-linking
material [17,18] prepared sodium alginate beads comprising with
voglibose as a drug candidate using emulsion gelationmethod. They re-
ported that the oil entrapped calcium alginate gel beads showed
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the mechanism of external and internal gelation method for the prepa-
ration of alginate micropellets and they reported that the external
gelation method produces cross-linked micropellets with greater
drug encapsulation efficiency (EE) and slower drug release [19,20].
Benavides et al., (2012) formulated alginate films containing oregano
essential oil and they evaluated the impact of the degree of crosslinking
due to the presence of the cross-linking agent and antibacterial effect,
optical, mechanical, microstructural and water vapor barrier properties
[20]. Brachkova et al. [21] developed calcium alginate films which con-
tain Lactobacillus plantarum ATCC 8040. They concluded that the films
help to preserve both viability and antibacterial action of lactobacilli.
However, the scientific literature has not so far reported in details re-
garding the formulation of alginate composite films with different de-
grees of crosslinking obtained by external gelation method. Gelation is
a more difficult physicochemical method and can be affected by various
factors which further influence the final properties of the film. There-
fore, considering all of the above facts the alginate films containing
diclofenac sodium as a drug candidate was prepared and investigated
the application of external gelation method for the film preparation.
This investigation demonstrates how the different factors affect the per-
meability nature of the prepared alginate films. The interaction of the
drug with polymers was done by FT-IR and DSC analysis. In vitro disso-
lution studies of the film containing drug was also carried out. Physico-
chemical characterization of alginate films was further performed to
know the different properties of the films in details. The aim of this in-
vestigation was to prepare and study the sustained release of the drug
from alginate films.
2. Materials and methods
2.1. Materials
Diclofenac sodium was procured from a local supplier as bulk. So-
dium alginate, hydroxyl propyl methyl cellulose (HPMC), polyvinyl-
pyrrolidone (PVP), calcium chloride, and hexahydrate were purchased
from Merck, India. All other chemicals, solvents used in this research
are of analytical grade.
2.2. Preparation of the films
2.2.1. Process 1
In this method, at first sodium alginate is dissolved in water prop-
erly. When it is ready, it may give a yellow colour. Then some drops of
glycerol were mixed it properly. The solution is ready to dry and when
it is dried by vacuum drying oven properly, alginate films are prepared.
In 60 ml water, 5% (3 g) sodium alginate is taken. Sodium alginate was
dissolved properly into the water. When the solution colour is changed
into yellow, then 10 drops of glycerol (25%) for F1 and 12 drops of glyc-
erol for F2was added. Then it wasmixed properly and this solutionwas
taken in four same containers (15 ml*4). Then all of them were dried
properly at 60 °C. Two alginate films (F1 and F2) were ready for further
use.
2.2.2. Process 2
In this process, at first, HPMC was taken and was dissolved in water
properly. When the solution was prepared, sodium alginate was added.
It wasmixed very well. When this was ready, then add glycerol and the
solutionwasmixed properly. Then the solutionwas left for drying in the
dryer. When the solution was dried properly, alginate/HPMC film was
prepared. In 60 ml water, 1.5% (0.9 g) HPMC was taken and was dis-
solved. Then 3.5% (2.1 g) sodium alginate was added to the solution.
Then the solution was mixed properly and 12 drops of glycerol (25%)
was mixed. The solution was taken into four same containers and the
solution was dried at 600C temperatures. When drying is completed,
the alginate-HPMC films (F3) were prepared (15 ml* 4).2.2.3. Process 3
In this process, PVA was dissolved in hot water. Then sodium algi-
nate was added. When it was done, glycerol was added. Then the solu-
tion was dried in a vacuum oven. When drying was done, alginate/PVA
film was prepared. In 60 ml water, 1.5% (0.9 g) PVA was taken and was
mixed properly into hot water. When the solution was ready, then 3.5%
(2.1 g) sodium alginatewasmixed. Then 12 drops of glycerol (25%)was
mixed and was poured into four same containers. After drying at 60 °C
temperature properly (15 ml*4), it is dried and alginate-PVA film (F8)
is prepared.
2.2.3.1. Treated with CaCl2 for the preparation of the Ca-alginate film
2.2.3.1.1. Treatment 1. When alginate film (F2) was ready, it was
treated with CaCl2 (0.2% w/v and 0.3% w/v) solution for 1 h. Then it
was dried and treated alginate films were prepared (F4 and F5).
2.2.3.1.2. Treatment 2. When alginate/HPMC film was ready, it was
treated with CaCl2 (0.2% w/v and 0.3% w/v) solution for 1 h. Then it
was dried and treated alginate/HPMC film was prepared (F6 and F7).
2.2.3.1.3. Treatment 3. When alginate/PVA film was ready, it was
treated with CaCl2 (0.2% w/v and 0.3% w/v) solution for 1 h. Then it
was dried and treated alginate/PVA film was prepared (F9 and F10).
2.3. Characterization of films
2.3.1. Determination of film weight and thickness
To evaluate the weight of the prepared films, three (3 × 2 cm2)
square shaped films from each formulation were cut and balanced
using a digital balance (Mettler Toledo, USA). The thickness of each
film was measured by means of a micrometre. The film thickness at dif-
ferent locations of each film was measured. Finally, the average weight
of each film per cm2 was calculated [22].
2.3.2. Folding endurance
To evaluate the folding endurance of the films, the complete film
was used. It was determined by repetitively folding the film at the
same place at the rate of 30–35 folds/min till it broke. The number of
times the film could be folded at the same place without breaking
gave the value of the folding endurance of the film [22].
2.3.3. Determination of surface pH and moisture content
To determine the surface pH, two films of (2 cm×2 cm) each formu-
lation was taken. The film is dissolved in 15 ml of distilled water. Then
allow it to rotate for completely dissolve with the help of a magnetic
stirrer. For each film, the pH ismeasuredwith the help of pHmeter [23].
For the determination of moisture content study, two squares (2 cm
×2 cm) shaped film of each formulationwas cut by using sharp scissors.
The square-shaped film was weight and kept in a vacuum drier for 1 h.
Then the film was removed from the drier and weight took until a con-
stant weight was achieved. The percentage moisture content value was
determined using the following equation.
Moisture content
¼ Initial weight of the film−Final weight of the filmð Þ=Initial weight of the film
100
2.3.4. Measurement of mechanical properties
The polymeric films which are proposed as a dosage form for drug
delivery should possess sufficient mechanical strength to withstand
from any damage during manufacture, handling, and use. The tensile
strength is defined as the maximum stress (σ) persistent by the mate-
rial. The tensile strength of the prepared film can be varied according
to the compositions of the formulations.
To determine the mechanical properties of the polymeric film, at
first the film was cut into a rectangle (30 × 15 mm). Then the
Table 1
Formulation details used for the preparation of films.
Formulation code Formulation methods Treated with CaCl2
F1 – No
F2 – No
F3 – No
F4 Same as F1 Treat with (0.2%)
F5 Same as F2 Treat with (0.3%)
F6 Same as F3 Treat with (0.2%)
F7 Same as F3 Treat with (0.3%)
F8 – No
F9 Same as F8 Treat with (0.2%)
F10 Same as F8 Treat with (0.3%)
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was controlled by means of a pneumatic grip controller fixed on a test
stand to align the long axis of the sample and the grip through an imag-
ined line linking the points of connection of the grip to the instrument.
The two grips were set aside at a space of 100mm in the identical level.
Lower grip was fixed and the upper one wasmoved linearly away from
the previous at a speed of 1 mm/s. The stress-strain curve was docu-
mented and tensile strength, percentage elongation at breakwas deter-
mined using the following equation:
%Elongation at breaks ¼ increase in length=original lengthð Þ
 100=cross−sectional area mm2 :
Tensile strength σð Þ
¼ force at breaks gmð Þ=Initial cross−sectional area of the sample:
2.3.5. FT-IR analysis
The Fourier Transform Infrared Spectroscopy of F1, F4, F6, F9, and
F10 films were performed by means of an Attenuated Total Reflectance
(ATR) Bruker FTIR (Tensor 27 series, Germany) by placing the samples
directly employed in sample holder and scanning was accomplished
in a range of 4000–400 cm−1 wave numberwith a resolution of 2 cm−1.
2.3.6. Differential scanning calorimetry (DSC)
Differential Scanning Calorimetric (DSC) analysis was performed to
characterize the thermal nature of the prepared film. Initially, after re-
moving the moisture by heating those samples, each sample was ex-
actly weighed into a platinum container 40-ml aluminium pan under
hermetically closed conditions, where alpha alumina powder was
used as a reference. Then each thermogram was recorded from 30° to
400 °C at the heating speed of 10 °C per min under a constant nitrogen
gas stream rate of 150 ml/min. Differential scanning analysis was done
using a Pyris-Diamond TG/DTA instruments (PerkinElmer, Singapore)
[24].
2.3.7. Scanning Electron Microscopy (SEM)
The surface morphology of the selected films was analyzed using
Scanning Electron Microscope (SEM, JSM-6700F, JEOL Ltd., Japan) at
17 kV. Prior to the analysis a completely dry film was employed on a
metal stub using double-sided adhesive tape and was treated with a
skinny layer of platinum for the 60s in reduced pressure of 2.54 Pa; at
a voltage of 10 kV, current of 25 mA by means of an ion sputtering de-
vice (Auto Fine Coater, JFC-1600, JEOL Ltd., Japan) [25].
2.3.8. Swelling study
Double distilled water was used as a medium for film swelling stud-
ies. Each film sample with (2 cm × 2 cm) of the surface area was
weighed and placed in the water. At scheduled time intervals, the ap-
pearance of the swelled film was observed [26].
2.3.9. Release study
In vitro drug release study was done in phosphate buffer media by
means of Franz diffusion cell test apparatus at 50 rpmand 37 °C temper-
ature. The diffusion process was done by selecting a portion of the film
in the donor section and 50ml of phosphate buffer was given to the dis-
solution bowl. At a regular time interval, 1 ml sample was withdrawn
and substituted by the same volume of dissolution media. The amount
of drug release was examined with a double beam UV–visible spectro-
photometer at a defined wavelength.
2.3.10. Release kinetic study
The drug release kinetics from films are done by using different
equations such as Zero-order (cumulative percentage drug release vs.
time), First order (log percentage drug remaining to release vs. time),
Higuchi (t half vs cumulative percentage drug release), Hixson-Crowell cube root equation (cube root of drug percentage remaining
to be released vs time), Korsmeyer-Peppas (log cumulative percentage
drug release vs. log time) which can be expressed as MtM∞ ¼ Ktn , where
Mt,M∞ are the quantity of drug release at time t and infinite time corre-
spondingly, K is the constant and n denotes diffusion exponent of drug
discharge. If the value of n=0.43 or less, themechanismof drug release
is Fickian and if the value of n lies stuck between 0.43 and 0.85 it is non-
Fickian and if the value of n = 0.85 it is case II transport and if N0.85, it
denotes super case II transport [27].
2.4. Statistical analysis
All the data were expressed as a mean standard deviation (SD). The
assessments among groups were done using Student's t-test. A p-value
b 0.05 was considered as indicative of significance whenever necessary.
3. Results and discussions
Calcium alginate films with altered degrees of cross-linking were
produced by external gelation method. Formulation details used for
the preparation of films are given in Table 1. The pictures of untreated
and treated films are given in and Fig. 1a and b respectively. All the pre-
paredfilmswere found smooth and flexible in nature. The alginate films
which were treated are found compact and compressed and they
showed slight transparency in nature. In this research work, we devel-
oped films comprising with alginate and diclofenac sodium, for its use
in an inflammatory condition. Fundamental properties of the film such
as thickness, transparency, swelling behaviour and in vitro dissolution
studies were carried out to assess the potential use of these films for
pain management, inflammation and joint stiffness.
3.1. Film weight, thickness and folding endurance
The variation in weight per cm2 of the film and the thickness of the
film were observed. This difference is seen because of the variation in
the nature of the polymer and their different ratios in films. It also de-
pends on crosslinking agents. Results are shown in Table 2. It was ob-
served, an increase of the tensile strength as an amount of glycerol
increases in the formulation. Plasticizing property of the glycerol pro-
duced improved folding endurance of the films [28]. Treated films
showed less flexibility than the untreated films.
3.2. Surface pH and moisture content
Surface pH of the polymeric films (F1–F10) was slightly acidic
(pH 4.0–pH 5) in double distilled water, i.e. the skin pH and it will re-
main unchanged after administration of films. This will ensure the
films may act as non-irritant to the skin. The percentage of moisture
content of the different films was shown to be in between 6.25 and
10% (w/w). Moisture content prevented films from drying completely.
Fig. 1. Untreated films (a), treated films (b).
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The mechanical property of alginate films were affect significantly
by the level of CaCl2 used in the external gelation process. An increase
in the values of tensile strength (TS) was observed with treated films.Table 2
Physicochemical properties of films.
Code Weight
(gm)
Thickness
(mm)
Wt/cm2
(gm/cm2)
Tensile strength
(g/mm2)
F1 0.96 0.13 0.0157 7.70
F2 1.11 0.14 0.0183 8.00
F3 0.82 0.15 0.0130 5.50
F4 1.34 0.16 0.0287 Very Strong
F5 1.45 0.26 0.0295 Very Strong
F6 1.02 0.18 0.0230 Very Strong
F7 1.09 0.20 0.0240 Very Strong
F8 0.82 0.15 0.0130 Very strong
F9 1.09 0.24 0.0240 Not done
F10 1.20 0.28 0.0250 Not doneThese results are explained by the advance of an extra rigid polymer
compositionwith reducedmobility of polymer chains as a consequence
of interactions among carboxyl groups of the alginate chain and calcium
ions.When some amount of alginatewas replaced byHPMC, it produces
a smooth and flexible film even after ion treatment.
3.4. FT-IR analysis of alginate films
The FT-IR spectrum of formulation F1 (Fig. 2a), showed the charac-
teristic absorption bands for hydroxyl groups were found at
3430.30 cm−1, stretching vibrations of aliphatic C\\H was found at
2931.77 cm−1, carboxylate at 1409.91 cm−1 and carbonyl at
1600.04 cm−1 which was due to the presence of sodium alginate in
the formulation [29,30]. The bands at 1088.20 and 942.34 cm−1 were
attributed to the C\\O stretching vibration of the pyranosyl ring and
the C\\O stretching with contributions from C–C–H and C–O–H defor-
mation [31]. Whereas in F4 (Fig. 2b) absorption bands for hydroxyl
groups was found at 3351.71 cm−1, carboxylate groups at
1415.18 cm−1 and carbonyl band were found at 1600.24 cm−1 and
which was almost similar as formulation F1. The FTIR spectra of F6
(Fig. 2c) showed the characteristic peak at 3371.32 cm−1 due to OH vi-
brational stretching; symmetric stretching mode of methyl and hy-
droxyl propyl groups was found at 2927.60 cm−1 in which all the CH
bonds extend and contract in phase; the peak at 1632.97 cm−1 indi-
cated the presence of stretching vibration six-membered cyclic rings
which were due to the presence of HPMC. In F6, the asymmetric bend-
ing vibrations of themethoxy group due to the presence of HPMC in that
formulation found at 1416.72 cm−1 [30]. In F9, absorption bands found
at 2922.40 cm−1 for C\\H stretching from alkyl groups, 1424.42 cm−1
for CH2 and 1079.61 cm−1 for C-O-C stretching (Fig. 2d) and these
bandswas due to the presence of PVA in the formulation. In F10, absorp-
tion bands found at 1419.81 cm−1 for CH2 and 1083.79 cm−1 for C-O-C
stretching (Fig. 2e) and these bands were due to the presence of PVA in
the formulation. FTIR spectra of the pure drug (Fig. 2f) exhibited charac-
teristic peaks at 3218.73 cm−1, 1572.66 cm−1 (-C=O stretching of car-
boxyl ion), 1548 cm−1 (∕ \C = C ∖ ∕ring stretching) and at 747.29 cm−1
(C-cl stretching). FTIR spectra of the drug-loaded film (Fig. 2g) contain-
ing sodium alginate along with HPMC shows few characteristics peaks
of the drug at 1571.09 cm−1 (-C=O stretching of carboxyl ion),
1552 cm−1 (∕ \C = C ∖ ∕ring stretching) and at 740.81 cm−1 (C-cl
stretching) respectively and slightly shifted when compared with the
pure drug.
3.5. Thermal characteristics
TheDSC curve of formulation F1 (Fig. 3), shows a broad endothermic
peak around 90 °C and a sharp exothermic peak at 220 °C and these
peaks was due to the presence of sodium alginate in the formulation
[32]. In the case of formulation F4, a broad endothermic peak was
found at 70 °C and a broad exothermic peak at 250 °C. The DSC curve
of formulation F6 shows a broad endothermic peak at around 80 °C
and a broad exothermic peak around 250 °C; the endothermic peakElongation at break (mmˉ2) Moisture content (%) pH in water
0.646 10 4.5
0.779 6.25 5
0.805 6.25 5
Very tough 6.25 5
Very tough 6.25 5
Very tough 6.25 4
Very tough 6.25 5
Very tough 10 4
Not done 6.25 4
Not done 6.00 4
Fig. 2. FTIR spectra of (a) F1, (b) F4, (c) F6, (d) F9, (e) F10, (f) diclofenac sodium, (g) film containing (sodium alginate+ diclofenac sodium + HPMC).
649K. Ghosal et al. / International Journal of Biological Macromolecules 130 (2019) 645–654was due to the presence of HPMC and exothermic peak around 250 °C
was due to the presence of sodium alginate in the formulation. In case
of formulation F9, a broad endothermic peak at 175 °C–199 °C indicating
itsmeltingpoint [33] and a broad exothermic peak at 220 °C. For the for-
mulation F10, a broad endothermic peakwas found at 75 °C and a broad
exothermic peak at 210 °C. In the DSC graph (Fig. 3b), sharpmelting en-
dotherm of diclofenac sodium was observed at 287.89 °C and the data
obtained was supported by the earlier researchers [34]. DSC thermo-
gramof the film (Fig. 3c) exhibited a broad endothermic peak at around
95 °C which may be due to the removal of loosely bound water present
in sodium alginate. The thermogram also showed a broad exothermic
peak at around 254 °C which was owing to the pyrolysis reaction in so-
dium alginate [35]. In the DSC thermogram showed that the decompo-
sition of the carbonaceous material in sodium alginate was found at a
temperature above 320 °C. In this film, the drug peak at 287.89 °C was
missing which could be due to the encapsulation of drug in the poly-
meric material. In this film, there was a peak observed at 142.99 °C
which was slightly shifted from reported value and this supports the
thermal stability of the film [36].
3.6. SEM images
Ca-alginate filmswere synthesized in two steps. After preparation of
Na-alginate films or composite films, the films were treated with CaCl2
as an external cross-linking agent for the preparation of Ca-alginatefilm. In some study [37], it had been seen that at the same time with
an external cross-linking agent, also an internal cross-linking agent (su-
crose) was used and their effects on surface morphology over the films
were investigated by SEM. In this research, we have observed exclu-
sively the effect of an external cross-linking agent on the morphology
of composite films. After preparation of the Ca-alginate film, the films
were not washed with water for the removal of untreated residue pres-
ent on the film and their presence in the form of small lumps or aggre-
gates was observed in SEM study (Fig. 4). SEM study showed that the
films appeared with different physical appearance depending on
cross-linking agent concentration and types of polymers. Untreated
films such as F1 showed smooth structured films whereas all treated
films could be seen folded in different extent. Usage of the cross-
linking agent had pronounced on effect on film appearance. The rate
of external gelation method both for Na-alginate film and composite
film appeared to be rapid which indicated that polymers
interpenetrated very well in composite films and gelation method oc-
curred throughout the surface. Presence of other polymers (PVP and
HPMC) with Na-alginate didn't hamper cross-linking interaction
whereas as the presence of lactose or sucrose did the opposite [38].
3.7. Swelling study
Untreated films dissolved very quickly [39] but treated films keep
their structure firm even after 5–6 h study (Fig. 5). Biodegradable and
Fig. 3. DSC thermograms of: (a) F1, F4, F6, F9 and F10, (b) diclofenac sodium, (c) film containing (sodium alginate + diclofenac sodium + HPMC).
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polymers (alginate, HPMC and PVP) in different ratios and their poly-
meric chains have interpenetrated to form interpenetrating polymeric
network based composite (IPN)film. All polymers are hydrophilic in na-
ture and these composites films dissolved in presence of water very
quickly. The faster rate of swelling and subsequent solubility was seenin Na-alginate film alone along with composite film based on Na-
alginate and HPMC based film in comparison to a composite film
based on Na-alginate and PVP. Here swelling study proved that without
any external gelation methods, the prepared films were not suitable for
controlled release formulation. As soon as, the treated film came in con-
tact with the fluid, it started to swell at a very faster rate. But when
Fig. 4. Micrographs of the surface of F1, F4, F6, F9, and F10 films.
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using an ionic cross-linking agent, treated films came upwith low solu-
bility. The advantages of composite films were that swellability of films
can bemanipulated in a wider range and these kinds of composites will
be useful for drugs that need controlled release which is very requisite
for the formulation of the pharmaceutical product. Through changes
in swelling property of the composite via external gelation,methods de-
pend on polymer type [40], crosslinking time and concentration. If
treated films made of only Na-alginate their swelling property were
least and these are more controlled for a prolonged period. But when
a certain amount of Na-alginate was replacing by HPMC, swelling im-
proved a bit but still, they are suitable for controlled release of the
drug. So these newly synthesized treated composite films may be con-
sidered or exploited as a novel formulation for controlled delivery ofdrugs with a wide range of their features, such as half-life, dose, hydro-
phobicity, and pH sensitivity.
3.8. Release study
Fig. 6, depicts the cumulative percentage release data of diclofenac
from untreated and treated films at different time interval at a temper-
ature of 37± 0.5 °C. It was observed that the drug release fromdifferent
formulations was dependent on the type of polymer used in the formu-
lation. The cumulative percentage release of drug from untreated Na-
alginate film (F2) was ~97% after 4 h, whereas the cumulative percent-
age of drug release from the untreated composite film (Na-alginate and
HPMC; F3) was found to be ~99% after 2 h. The presence of HPMC with
Na-alginate significantly can enhance the release of the drug. It was
Fig. 5. Swelling study of the films.
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viscosity was blended with Na-alginate, so retarding efficiency of
HPMC toward drug release was comparatively lower than Na-alginate
and as a result, the composite film releasedmore amount of drug at spe-
cific time intervals. In both of the cases, the release profile mainly
followed by the initial burst release of the drug by a continuous release.
The release data showed that at thefirst hour, amaximumof 32% to 35%Fig. 6. Cumulative % drug release from films.of the drug was released from both films. Drug for initial burst release
mainly comes from the surface of films where drugs loosely interacted
with films. The drug which was trapped inside thematrix only released
when the polymer started to swell and drug release started through the
loose matrix. Then release study from treated films was performed to
study the effect of external gelation method on drug release from for-
mulations. For the release study, F4 and F6 were chosen. Drug release
from F4 formulationwas found to be 37.34% at 5 hwhereas drug release
fromF6was found to be 53.25% at 4 h. So in both cases, it has been found
that external gelation method has sustained their release film signifi-
cantly. By this simple procedure, the biocompatible, biodegradable hy-
drophilic polymer can be manipulated for the requirement of drug
release. Differences in drug releases in both F4 and F6 again was the
same as stated above, it wasmainly due to the type of polymers [41–43].
3.9. Release kinetic study
Amount of drug release or mode of drug release from a formulation
is always determined by kinetic models. The release pattern of the drug
fromdosage form depends on different factors whichmay be drug's sol-
ubility, the particle size of the drug, its crystallinity, amount of the drug
and also the type of formulationswhere the drug is encapsulated. Differ-
ent kinetic models are used to describe release kinetic patterns such as
Zero-order, First order, Higuchi, Hixon-Crowell and Korsmeyer-Peppas.
The mathematical expressions for the empirical/semi-empirical models
are shown in Table 3.
The drug release from the formulation F6, F3, F4, and F2were shown
in Fig. 6. After fitting the drug release data from above-mentioned films
in different kinetics models, it revealed that the release of drug from
these formulations was explained by different mechanisms. Based on
the observation (Table 4), drug release from F2 was best explained by
the Higuchi model.
To determine the best drug release kinetics, the highest correlation
coefficient values (r2) were selected. The drug release kinetics from F6
was best explained by Hixon-Crowell model. According to Korsmeyer-
Peppas model, the value of release exponents (n) for F6, F3 and F2
films ranging from 0.47 to 0.59 which indicates non-Fickian transport
whereas film F4 (n = 0.36) follows Ficikian diffusion [44–49].
3.10. Statistical analysis
All results are calculated as mean values and the values are statisti-
cally significant.
4. Conclusions
In the present work, the Ca-alginate films containing diclofenac so-
dium a potential NSAIDS were formulated using different procedures.
Observations showed that the properties of alginate films were affected
by the addition of CaCl2. The cross-liked films prepared by external ge-
lation method showed high tensile strength, low elongation with po-
rous microstructure. The selected formulation F4 and F6 showed the
drug release was 37.34% after 5 h and 67.11% release after 5 h respec-
tively. The possible mechanism for this sustained release of the drugTable 3
Mathematical model for the kinetic release.
SL. no. Model Equation
1 Zero-order Qt = K0 t + C0
2 First-order Qt = Q0exp (−Kf) t
3 Higuchi Qt = KH√t + CH
4 Hixon-Crowell Q01 / 3- Q t1/3 = Ks t
5 Korsmeyer-Peppas Qt/Q∞ = Ktn
Qt: cumulative percentage of drug released at time t, Q0 is the initial amount of drug, K0, Kf,
KH, Ks, K is release rate constants for zero-order, first-order, Higuchi, Hixon-Crowell and
Korsmeyer-Peppas respectively.
Table 4
Mathematical models with kinetic fitting results of the Ca-alginate films.
Code Zero-order First order Hixson-Crowell Higuchi Korsmeyer-Peppas
Ko (h−1) r2 K1 (h−1) r2 KHC (h-1/3) r2 KH (h-1/2) r2 KKP (h-n) r2 n
F6 9.893 0.9732 −0.0838 0.9288 −0.2637 0.9908 28.4348 0.9707 0.2386 0.9756 0.59
F3 25.275 0.9992 −0.7955 0.8736 −0.4918 0.9982 63.7288 0.9856 0.4836 0.9998 0.57
F4 3.151 0.9579 −0.0201 0.9594 −0.1051 0.9542 16.6952 0.9472 0.2214 0.9302 0.36
F2 15.441 0.9968 −0.3820 0.8916 −0.2987 0.9959 47.6734 0.9990 0.4906 0.9984 0.47
653K. Ghosal et al. / International Journal of Biological Macromolecules 130 (2019) 645–654from the films is external gelation method. The functional properties of
the films were changed significantly when polymer PVA and HPMC
were added. The effect on the release profile was also observed and
this is due to the polymer as they alter the alginate films properties.
The SEM imaging of thefilms showed an apparent effect of the polymers
on the surface. So from the above findings, it has been found that exter-
nal gelation method has sustained the drug release from the prepared
film significantly.Conflict of interest
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